超声引导下竖脊肌平面阻滞用于腹腔镜肾切除术患者围术期镇痛:一项随机对照试验
本研究为单中心随机对照试验,将50例拟行腹腔镜肾切除术的肾癌患者按1:1随机分为竖脊肌平面阻滞(ESPB)组和对照组,旨在评估ESPB的疗效。主要结局为术中舒芬太尼总消耗量,次要结局包括术后多个时间点静息和咳嗽时VAS评分、术中瑞芬太尼总消耗量、需要补救镇痛次数及术后24小时内恶心呕吐发生率。研究在中国开展,注册时长1年,已获陆军军医大学第二附属医院伦理委员会批准。
要点
- 主要结局为术中舒芬太尼总消耗量;次要结局包括术后1、6、12、24、48小时VAS评分等。
- 研究将右美托咪定和地塞米松加入神经阻滞方案,关注其对阻滞质量和持续时间的影响。
核心结论
- 研究旨在评估ESPB对腹腔镜肾切除术患者的潜在获益,并关注右美托咪定和地塞米松作为佐剂对阻滞质量与持续时间及术后疼痛和阿片类药物消耗的影响。
- 作者希望为神经阻滞中佐剂应用提供更多文献证据,并进一步了解该方法改善腹腔镜肾切除术后患者结局的潜在获益。
研究设计与样本
- 单中心随机对照试验,50例受试者按1:1比例随机分配至ESPB组或对照组。
- 研究对象为诊断为肾癌并拟行腹腔镜肾切除术的患者。
- 研究在中国开展,注册时长为1年。
- 试验已获陆军军医大学第二附属医院伦理委员会批准。
- 试验注册于中国临床试验注册中心,注册号ChiCTR2300068578,注册日期2023年2月20日。
主要发现
- 主要结局指标为术中舒芬太尼总消耗量。
- 次要结局包括术后1小时、6小时、12小时、24小时和48小时静息及咳嗽时VAS评分。
- 次要结局还包括术中瑞芬太尼总消耗量、需要补救镇痛的次数以及术后24小时内恶心呕吐的发生率。
临床怎么用
- 作者将右美托咪定和地塞米松加入本研究的神经阻滞方案。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic nephrectomy is a commonly utilized surgical approach for the management of renal cancer. Despite its widespread acceptance, postoperative pain management remains a significant challenge for many patients undergoing this procedure. Traditional pain management techniques, including opioid and nonsteroidal anti-inflammatory drug administration, may not provide adequate pain relief and may result in adverse effects. In recent years, erector spinae plane block (ESPB) has emerged as a promising regional anesthesia technique due to its simplicity, safety, and potential efficacy in reducing postoperative pain. ESPB has demonstrated effectiveness in reducing postoperative pain in various surgical procedures. However, the efficacy of ESPB in laparoscopic nephrectomy for renal cancer has not been extensively studied. As such, further investigation is necessary to determine the potential benefits of ESPB in this context. The addition of adjuvants such as dexmedetomidine and dexamethasone to nerve blocks has been shown to improve both the duration and quality of the block. Multiple studies have demonstrated the safety and efficacy of these adjuvants in reducing postoperative pain and opioid consumption and improving patient satisfaction. The use of dexmedetomidine and dexamethasone as adjuvants for nerve blocks represents a promising approach for enhancing regional anesthesia and analgesia. In light of these findings, we have incorporated dexmedetomidine and dexamethasone into our nerve block protocol. METHODS: This study is a randomized controlled trial conducted at a single center, with 50 participants being randomized in a 1:1 ratio to either the ESPB group or the control group. The trial aims to investigate the efficacy of ESPB in patients diagnosed with kidney cancer who are scheduled for laparoscopic nephrectomy. The primary outcome measure is the total consumption of intraoperative sufentanil. Secondary outcomes include the VAS score at rest and during coughing at 1 h, 6 h, 12 h, 24 h, and 48 h after surgery; total intraoperative remifentanil consumption; the number of times rescue analgesia is required; and the incidence of nausea and vomiting in the first 24 h after surgery. This study is registered for a duration of 1 year and is being conducted in China. DISCUSSION: The objective of our study is to evaluate the potential benefits of erector spinae plane block (ESPB) in patients undergoing laparoscopic nephrectomy, with a focus on the impact of dexmedetomidine and dexamethasone as adjuvants on the quality and duration of the block, as well as postoperative pain and opioid consumption. By investigating the effects of these adjuvants in the context of ESPB, we hope to contribute to the growing body of literature on the use of adjuvants in nerve blocks and provide further insight into the potential benefits of this approach for improving patient outcomes following laparoscopic nephrectomy. This trial was approved by the Ethics Committee of the Second Affiliated Hospital of Army Medical University. TRIAL REGISTRATION: China Clinical Trial Register ChiCTR2300068578 . Registered on 20 February 2023.
引用
- Yang M, Cao L, Lu T, et al. Ultrasound-guided erector spinae plane block for perioperative analgesia in patients undergoing laparoscopic nephrectomies surgery: a randomized controlled trial. Trials. 2024. PMID: 38167138. doi:10.1186/s13063-023-07866-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。